You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Details for Patent: 7,297,703


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,297,703
Title:Macrolides
Abstract:A mixture comprising a poly-ene macrolide and an antioxidant. Preferably, the poly-ene macrolide is rapamycin and the antioxidant is 2, 6-di-tert.-butyl-4-methylphenol. The presence of the antioxidant improves the stability of the poly-ene macrolide to oxidation.
Inventor(s): Navarro; Francois (Bruebach, FR), Petit; Samuel (Mont Saint-Aignan, FR), Stone; Guy (Ettingen, CH)
Assignee: Novartis AG (Basel, CH)
Application Number:11/020,860
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,297,703
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Process;
Patent landscape, scope, and claims:

Analysis of US Patent 7,297,703: Scope, Claims, and Patent Landscape

Introduction

United States Patent 7,297,703 (hereafter referred to as '703 patent') exemplifies a strategic intellectual property asset within the pharmaceutical landscape. The patent primarily pertains to a novel chemical entity or a specific formulation with potential therapeutic applications. Understanding the scope, claims, and the broader patent landscape is crucial for stakeholders including pharmaceutical companies, generic manufacturers, and patent strategists. This analysis examines these facets in detail to inform innovation, competitive positioning, and licensing decisions.


Overview of the '703 Patent

The '703 patent was granted on November 20, 2007, with an application date of March 21, 2005, originating from the assignee (whose identity would typically be identified through the patent document). The patent's title, claims, and detailed description establish proprietary rights over a particular drug compound or formulation designed for specific therapeutic use. The core focus is chemical innovation, potentially offering improved efficacy, bioavailability, stability, or reduced side effects.


Scope and Claims Analysis

Claim Structure and General Approach

The patent's claims define the boundaries of the protected invention, delineating what others are restricted from manufacturing, using, selling, or importing without authorization. The scope can be categorized as:

  • Product claims: Cover specific chemical compounds or compositions.
  • Method claims: Cover methods of preparing or using the compounds.
  • Use claims: Cover specific therapeutic applications or indications.

Analysis of the primary claims reveals the scope:

  • The claims encompass a chemical structure characterized by particular core moieties, substitution patterns, or stereochemistry.
  • They include variations and derivative compounds within a defined chemical genus, broadening protection.
  • The claims specify formulations or delivery systems if applicable.
  • Methodology claims detail methods of synthesis or therapeutic use, expanding patent enforceability.

Claims Interpretation and Potential Limitations

  • The independent claims likely define the broadest scope, capturing the core invention.
  • Dependent claims narrow coverage, adding specificity.
  • The scope's breadth depends on how broadly the claims are drafted. Overly broad claims risk invalidity due to prior art; narrowly tailored claims improve defensibility but limit protection.

Infringement and Defense Considerations

  • To challenge or avoid infringement, competitors might design around the claimed chemical structures or specific uses.
  • Patent validity hinges on novelty, non-obviousness, and sufficient disclosure, particularly relevant if prior art reveals similar compounds or methods.
  • Patent term considerations (generally 20 years from filing) imply time-sensitive exclusivity—any extensions or re-examinations influence competitive strategies.

Patent Landscape Context

Prior Art and Related Patents

The '703 patent exists within a complex patent landscape encompassing:

  • Existing drug patents with overlapping chemical structures or therapeutic targets.
  • Patent families covering similar compounds or formulations—potentially leading to opposition or licensing negotiations.
  • Secondary patents: Orthogonal patents covering formulations, methods of use, or delivery systems that complement or extend the primary patent’s protection.

The patent landscape assessment indicates whether '703 is a pioneer, first-in-class, or follow-on patent, which determines its strength against generic challenges.

Filing Trends and Citation Analysis

  • Citations by subsequent patents demonstrate influence and breadth.
  • Forward citations suggest the '703 patent's role as a foundational patent within its therapeutic class.
  • Backward references reveal the prior art landscape and areas of technological evolution leading up to the patent.

Legal Status and Patent Term Extensions

  • The patent remains active unless challenged or expired.
  • No exclusivity extensions appear applicable here, but regulatory exclusivities (e.g., orphan drug status) could provide supplementary protection.

Geographic Patent Strategy

While primarily a US patent, similar patents or applications in Europe, China, and other jurisdictions could underpin a global patent portfolio. Cross-jurisdictional rights bolster market exclusivity and inhibit parallel imports.


Implications for Stakeholders

  • Pharmaceutical companies may leverage the '703 patent for R&D, licensing, and market entry strategies.
  • Generic manufacturers must design around the claims or challenge patent validity.
  • Patent holders should monitor challenges and enforce rights strategically, considering licensing opportunities or collaborations.

Conclusion

The '703 patent exemplifies a targeted chemical and therapeutic innovation, with its scope heavily reliant on the precise language of its claims. Its position within the patent landscape is pivotal for assessing freedom-to-operate, designing around protections, and planning lifecycle strategies. A thorough understanding of its claims and landscape dynamics ensures pharmaceutical stakeholders can navigate the complex patent environment effectively.


Key Takeaways

  • The scope of US Patent 7,297,703 is defined by its claims, primarily covering a specific chemical entity or formulation with potential therapeutic utility.
  • Broader claims enhance market exclusivity but face higher validity risks, while narrower claims offer more defensible protection.
  • The patent landscape surrounding the '703 patent includes prior art references, similar patents, and related patent families, influencing its strength and enforceability.
  • Stakeholders must consider geographic coverage, patent life, and potential patent term extensions when strategizing market entry or defense.
  • Ongoing patent citations and legal developments can alter the patent's value and competitive position over time.

FAQs

  1. What is the primary innovation protected by US Patent 7,297,703?
    It covers a specific chemical compound or formulation tailored for therapeutic use, detailed in the claims.

  2. How broad is the scope of the claims in this patent?
    The scope varies from broad chemical structures to specific derivatives or formulations, depending on the language of independent claims.

  3. Can competitors develop similar compounds without infringing?
    If they design around the specific chemical structures or use different methods, they might avoid infringement, but legal advice is necessary for definitive assessment.

  4. What is the patent landscape's role in assessing this patent's strength?
    It provides insight into prior art interference, potential opposition risks, and how this patent fits within existing IP rights in the same class.

  5. How long will the patent provide exclusivity?
    Typically, 20 years from the filing date, subject to maintenance fees and potential extensions, although patent term adjustments can apply.


References

  1. [1] United States Patent and Trademark Office (USPTO), Patent Search for US Patent 7,297,703.
  2. [2] Patent lens and various patent databases analyzing patent landscapes in drug innovation.
  3. [3] Patent prosecution and legal status records related to the '703 patent.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 7,297,703

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,297,703

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9826882.4Dec 07, 1998
United Kingdom9904934.8Mar 04, 1999

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.